The role of beta-lactamase inhibitors in chemotherapy.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D055598:Chemical Phenomena; D002621:Chemistry; D019818:Clavulanic Acid; D002969:Clavulanic Acids / Q000494:pharmacology; D006090:Gram-Negative Bacteria / Q000201:enzymology / Q000235:genetics; D006801:Humans; D007769:Lactams; D010397:Penicillanic Acid / Q000494:pharmacology / Q000031:analogs & derivatives; D013450:Sulfones / Q000494:pharmacology; D065093:beta-Lactamase Inhibitors; D001618:beta-Lactamases / Q000145:classification; D047090:beta-Lactams
D000900:Anti-Bacterial Agents; D002969:Clavulanic Acids; D007769:Lactams; D013450:Sulfones; D065093:beta-Lactamase Inhibitors; D047090:beta-Lactams; D019818:Clavulanic Acid; C020786:olivanic acid; C018008:brobactam; D010397:Penicillanic Acid; D001618:beta-Lactamases